Approval · Notice of Compliance 34577 · 2024
RYALTRIS: Notice of Compliance 34577
Issued December 17, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34577
- Date
- December 17, 2024
- Company
- Glenmark Specialty SaNeuchâtel, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYALTRIS | Not yet assigned | — |
Medicinal ingredients
- OLOPATADINE HCL 665 MCG per ACT
- MOMETASONE FUROATE MONOHYDRATE 25 MCG per ACT